Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

NCT01140997

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations
  • 302 Military Hospital Beijing, China
  • Beijing Youan Hospital, Capital Medical University Beijing, China
  • Beijing Youyi Hospital, Capital Medical University Beijing, China
  • Peking University First Hospital Beijing, China
View all 38 locations
View Trial Details
Completed

EFFicacy Optimization Research of Telbivudine Therapy

NCT00962533

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 302 Military Hospital of China Beijing, Beijing Municipality, China
  • Beijing Ditan Hospita Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital Attached to the Capital Medical University Beijing, Beijing Municipality, China
  • BeiJing YouAn Hospital ,Capital Medical University Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details
Completed

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

NCT00672191

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Practice Comprehensive Care Practice Div of Onfectious Disease & HIV Med Philadelphia, Pennsylvania, United States
  • Southern Alberta Clinic Calgary, Alberta, Canada
  • Providence Health Care Society / The University of British Columbia / BC Centre for Excellence in HIV/AIDS Vancouver, British Columbia, Canada
  • Hamilton Health Sciences - McMaster University Medical Centre Hamilton, Ontario, Canada
View Trial Details
Completed

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

NCT01159743

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
Locations
  • Site Reference ID/Investigator# 39595 Alicante, Spain
  • Site Reference ID/Investigator# 39602 Barcelona, Spain
  • Site Reference ID/Investigator# 39605 Barcelona, Spain
  • Site Reference ID/Investigator# 39589 Barcelona, Spain
View all 26 locations
View Trial Details

Related conditions